Rock Springs Capital Management LP Exact Sciences Corp Transaction History

Rock Springs Capital Management LP

$2.94 Billion
Q3 2024

A detailed history of Rock Springs Capital Management LP transactions in Exact Sciences Corp stock. As of the latest transaction made, Rock Springs Capital Management LP holds 1,147,500 shares of EXAS stock, worth $65.8 Million. This represents 2.66% of its overall portfolio holdings.

Number of Shares

1,147,500

Previous 1,081,500 6.1%

Holding current value

$65.8 Million

Previous $45.7 Million 71.0%

% of portfolio

2.66%

Previous 1.42%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$42.43 - $70.83 $2.8 Million - $4.67 Million	66,000 Added 6.1%	1,147,500 $78.1 Million
Q2 2024 Aug 14, 2024	BUY	$41.33 - $74.26 $898,927 - $1.62 Million	21,750 Added 2.05%	1,081,500 $45.7 Million
Q1 2024 May 15, 2024	BUY	$56.27 - $73.77 $2.26 Million - $2.97 Million	40,250 Added 3.95%	1,059,750 $73.2 Million
Q4 2023 Feb 14, 2024	BUY	$59.06 - $75.72 $73,825 - $94,650	1,250 Added 0.12%	1,019,500 $75.4 Million
Q3 2023 Nov 14, 2023	BUY	$65.94 - $99.04 $4.93 Million - $7.4 Million	74,750 Added 7.92%	1,018,250 $69.5 Million
Q2 2023 Aug 14, 2023	BUY	$62.68 - $95.05 $125,360 - $190,100	2,000 Added 0.21%	943,500 $88.6 Million
Q1 2023 May 15, 2023	BUY	$47.19 - $70.77 $2.55 Million - $3.82 Million	54,000 Added 6.08%	941,500 $63.8 Million
Q4 2022 Feb 14, 2023	BUY	$30.35 - $53.15 $9.38 Million - $16.4 Million	308,900 Added 53.39%	887,500 $43.9 Million
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $188,623 - $291,283	5,900 Added 1.03%	578,600 $18.8 Million
Q2 2022 Aug 15, 2022	BUY	$35.61 - $76.23 $96,147 - $205,821	2,700 Added 0.47%	572,700 $22.6 Million
Q1 2021 May 17, 2021	BUY	$116.57 - $155.01 $9.91 Million - $13.2 Million	85,000 Added 17.53%	570,000 $75.1 Million
Q4 2020 Feb 16, 2021	BUY	$99.61 - $142.12 $6.08 Million - $8.67 Million	61,000 Added 14.39%	485,000 $64.3 Million
Q1 2020 May 15, 2020	BUY	$37.9 - $104.44 $151,600 - $417,760	4,000 Added 0.95%	424,000 $24.6 Million
Q4 2019 Feb 14, 2020	SELL	$77.66 - $99.74 $912,505 - $1.17 Million	-11,750 Reduced 2.72%	420,000 $38.8 Million
Q3 2019 Nov 14, 2019	BUY	$90.37 - $122.49 $3.14 Million - $4.26 Million	34,750 Added 8.75%	431,750 $39 Million
Q1 2019 May 15, 2019	BUY	$61.98 - $96.5 $743,760 - $1.16 Million	12,000 Added 3.12%	397,000 $34.4 Million
Q3 2018 Nov 14, 2018	BUY	$48.29 - $80.6 $241,450 - $403,000	5,000 Added 1.32%	385,000 $30.4 Million
Q2 2018 Aug 14, 2018	BUY	$37.84 - $69.96 $359,480 - $664,619	9,500 Added 2.56%	380,000 $22.7 Million
Q1 2018 May 15, 2018	SELL	$39.82 - $57.53 $2.56 Million - $3.7 Million	-64,400 Reduced 14.81%	370,500 $14.9 Million
Q4 2017 Feb 14, 2018	SELL	$46.49 - $60.51 $116,225 - $151,275	-2,500 Reduced 0.57%	434,900 $22.9 Million
Q3 2017 Nov 14, 2017	BUY	$37.05 - $47.12 $16.2 Million - $20.6 Million	437,400	437,400 $20.6 Million

Others Institutions Holding EXAS

# of Institutions

674

Shares Held

163M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.

Account

Rock Springs Capital Management LP Exact Sciences Corp Transaction History